• Founders Fund Managing Partner Sean Parker attends the eG8 forum in Paris in this May 25, 2011 file photo. A $250 million grant from Silicon Valley billionaire Parker, announced on April 13, 2016, aims to speed development of more effective cancer treatments by fostering collaboration among leading researchers in the field.  REUTERS/Gonzalo Fuentes/Files - RTX29OXM
    April 13, 2016  

    Sean Parker made his fortune as the co-founder of Napster and first president of Facebook. Now, the tech entrepreneur and billionaire hopes to change medicine by creating a new kind of research network. Parker gave out a $250 million grant Wednesday to six of the nation’s leading medical schools and cancer centers to fund collaborative immunotherapy research. Parker joins Judy Woodruff for more. Continue reading

  • 179798078_slideshow
    May 11, 2014  

    A study this week says scientists have devised a new approach that represents the blueprint for making immunotherapy available to treat common cancers, and may allow doctors to target what is unique about each person’s cancer. Continue reading